Diabetic Nephropathy (Chronic Kidney Disease) secondary to Type 2 Diabetes Mellitus

Yes. Under 38 CFR § 3.310(a), any disability proximately caused or chronically worsened by a service-connected condition is itself service-connected. Diabetic Nephropathy (Chronic Kidney Disease) is a documented secondary pairing for Type 2 Diabetes Mellitus with strong medical evidence. A nexus letter from a qualified physician linking the two conditions is the most reliable way to establish this connection.

The gold standard is a private nexus opinion stating — to at least a 50% probability ("at least as likely as not") — that the secondary condition was caused or aggravated by the primary service-connected condition. Peer-reviewed medical literature supporting the physiological mechanism strengthens the nexus. Treatment records documenting the onset or worsening of the secondary condition in temporal relation to the primary are supporting evidence.

The VA rates Diabetic Nephropathy (Chronic Kidney Disease) separately under its own 38 CFR Part 4 diagnostic code, then combines it with Type 2 Diabetes Mellitus and all other service-connected ratings using the combined ratings formula under § 4.25. The formula applies the whole-person concept: a 50% combined existing rating plus a new 30% rating yields 65% (rounded to 70%), not 80%.

38 CFR § 3.310(a) states: "Disability which is proximately due to or the result of a service-connected disease or injury shall be service connected." The aggravation variant under § 3.310(b) applies where the primary condition permanently worsens a pre-existing disability beyond its natural progression. Both standards require a showing of nexus — a medical or scientific link between the primary condition and the secondary.

The medical evidence supporting Diabetic Nephropathy (Chronic Kidney Disease) as secondary to Type 2 Diabetes Mellitus is rated strong. Diabetic nephropathy is the leading cause of end-stage renal disease in the United States, affecting 20–40% of Type 2 diabetic patients. Hyperglycemia causes glomerular hyperfiltration through afferent arteriole dilation, followed by mesangial matrix expansion, glomerular basement membrane thickening, podocyte loss, and progressive glomerulosclerosis (Kimmelstiel-Wilson nodules on renal biopsy). Activation of the renin-angiotensin-aldosterone system (RAAS) by the diabetic kidney compounds intraglomerular hypertension. The clinical progression is: microalbuminuria → macroalbuminuria → decreased GFR → end-stage renal disease requiring dialysis or transplant. VA rates diabetic renal involvement under 38 CFR § 4.115b DC 7541, which directs "Rate as renal dysfunction", and the renal dysfunction formula in § 4.115a turns on GFR sustained for at least 3 consecutive months during the past 12 months, on regular routine dialysis, or on eligible kidney transplant status. DC 7101 is hypertensive vascular disease and is a separate rating, not the code for the kidney disease itself.

The VA will not solicit nexus evidence on your behalf for secondary claims. In practice, a written nexus opinion from a private physician or independent medical examiner is essential — the VA's Compensation & Pension (C&P) examiner is not required to produce a favorable nexus opinion, and the VA has discretion to weigh competing opinions. Submitting a private nexus letter at the time of filing is the most reliable strategy.